The Physical AI Shift in Post-Acute Care: Inside Inspiren's $500M+ Bet
Dr. Dereck Mush, MD, MBA
What they do
Basalt reads incoming post-acute referral packets and checks clinical and payer information against a facility’s admission criteria. It surfaces findings with source references for intake teams to review; a clinician makes the final admission decision. The company announced a $20 million Series A on September 24, 2026, bringing total funding to about $24.5 million.
The record
- Vertical
- Hospital Operations
- Sub-segment
- Post-acute admissions
- Product type
- Platform software
- Stage
- Series A
- Headquarters
- Not disclosed
- Region
- North America
- Founded
- Not disclosed
- Total funding
- $24.5M raised
Notable investors: New Enterprise Associates, Frist Cressey Ventures, 25m Health.
Also in Hospital Operations
Related on The Signal
Dr. Dereck Mush, MD, MBA
De Novo AI in the Acute Care Pathway: How Queen of Hearts Redefines Emergency Triage Economics and Cath Lab Utilization
Dr. Dereck Mush, MD, MBA
Why Well-Funded Digital Health Startups Keep Shutting Down: The Pattern Behind the Post-Mortems
Dr. Dereck Mush, MD, MBA
The EHR Dark Data Goldmine: Why Sentence-Level Provenance Is Pharma's New Real-World Evidence Moat
Dr. Dereck Mush, MD, MBA